Correlation Between Molecular Partners and Silo Pharma
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Silo Pharma, you can compare the effects of market volatilities on Molecular Partners and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Silo Pharma.
Diversification Opportunities for Molecular Partners and Silo Pharma
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Molecular and Silo is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Molecular Partners i.e., Molecular Partners and Silo Pharma go up and down completely randomly.
Pair Corralation between Molecular Partners and Silo Pharma
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 1.19 times more return on investment than Silo Pharma. However, Molecular Partners is 1.19 times more volatile than Silo Pharma. It trades about 0.0 of its potential returns per unit of risk. Silo Pharma is currently generating about -0.11 per unit of risk. If you would invest 567.00 in Molecular Partners AG on August 24, 2024 and sell it today you would lose (25.00) from holding Molecular Partners AG or give up 4.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Molecular Partners AG vs. Silo Pharma
Performance |
| Timeline |
| Molecular Partners |
| Silo Pharma |
Molecular Partners and Silo Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Molecular Partners and Silo Pharma
The main advantage of trading using opposite Molecular Partners and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.| Molecular Partners vs. Mineralys Therapeutics, Common | Molecular Partners vs. AN2 Therapeutics | Molecular Partners vs. Pharvaris BV | Molecular Partners vs. PepGen |
| Silo Pharma vs. Rezolute | Silo Pharma vs. Lumos Pharma | Silo Pharma vs. Anebulo Pharmaceuticals | Silo Pharma vs. Sino Biopharmaceutical Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |